A look at a promising drug to control cyst size, growth, and progression to ESRD in ADKPD patients.







**************************************

Estimated Time to View: 50 minutes
Title: Tolvaptan in the Treatment of Adult Polycystic Kidney Disease: TEMPO 3:4 Trial
Author: Marjan Vandevar, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2013, Volume 4, Number 6
Disclaimers: None
Resource Type: Video
Recommend to a Colleague/Friend: Roll Over
Review this teaching resource: Click here

Pin this resource

**************************************





LEARNING OPTIONS:


To view this 720p high-definition video using an iPad or iPhone, click on the video below

To read the Twitter transcript, click here





Transparent Peer Review



GD Star Rating
loading...



To learn more about our 6-point transparent peer review system, click here



Share

Comments

More in Cystic Diseases, General Nephrology, Miscellaneous (17 of 221 articles)


A comprehensive review of hypertensive trials leading up to ...